PRESS RELEASE published on 02/21/2023 at 14:30, 2 years ago Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 02/09/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
PRESS RELEASE published on 02/08/2023 at 14:30, 2 years 1 month ago Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
PRESS RELEASE published on 02/01/2023 at 15:45, 2 years 1 month ago Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
PRESS RELEASE published on 02/01/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
PRESS RELEASE published on 01/30/2023 at 14:30, 2 years 1 month ago Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
PRESS RELEASE published on 01/27/2023 at 22:15, 2 years 1 month ago Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE published on 01/26/2023 at 14:30, 2 years 1 month ago Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
PRESS RELEASE published on 01/25/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
PRESS RELEASE published on 01/23/2023 at 14:30, 2 years 1 month ago Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Published on 03/15/2025 at 00:40, 6 hours 31 minutes ago Star Copper Announces Execution of Arrangement Agreement For Spin-Out of Okeover Project
Published on 03/15/2025 at 00:00, 7 hours 11 minutes ago BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement
Published on 03/14/2025 at 23:20, 7 hours 51 minutes ago Organto Foods Provides Update on Strategic Plans
Published on 03/14/2025 at 22:55, 8 hours 16 minutes ago Alset AI Announces Filing of Audited Financial Statements
Published on 03/14/2025 at 21:59, 9 hours 12 minutes ago Apex Critical Metals Corp. Announces Grant of Stock Options
Published on 03/14/2025 at 20:20, 10 hours 50 minutes ago EQS-Adhoc: Gläubigerversammlung zur Anleihenverlängerung
Published on 03/14/2025 at 18:44, 12 hours 26 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/14/2025 at 17:55, 13 hours 15 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 03/14/2025 at 18:55, 12 hours 15 minutes ago Availability of ENGIE's 2024 Universal Registration Document
Published on 03/14/2025 at 18:00, 13 hours 11 minutes ago Availability of the 2024 Universal Registration Document of OPmobility SE
Published on 03/14/2025 at 16:55, 14 hours 16 minutes ago Closing of the agreement between ENGIE and the Belgian government
Published on 03/14/2025 at 11:34, 19 hours 36 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as at February 28, 2025
Published on 03/14/2025 at 08:44, 22 hours 27 minutes ago Aéroports de Paris SA - €1bn dual-tranche new bond issue
